TrialNeuro-oncology2024

Safety and efficacy of selumetinib in pediatric and adult patients with neurofibromatosis type 1 and plexiform neurofibroma.

Hyery Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.